1. Home
  2. ALG vs IBRX Comparison

ALG vs IBRX Comparison

Compare ALG & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALG
  • IBRX
  • Stock Information
  • Founded
  • ALG 1955
  • IBRX 2014
  • Country
  • ALG United States
  • IBRX United States
  • Employees
  • ALG N/A
  • IBRX N/A
  • Industry
  • ALG Industrial Machinery/Components
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALG Industrials
  • IBRX Health Care
  • Exchange
  • ALG Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • ALG 2.5B
  • IBRX 2.4B
  • IPO Year
  • ALG 1993
  • IBRX N/A
  • Fundamental
  • Price
  • ALG $198.02
  • IBRX $2.66
  • Analyst Decision
  • ALG Strong Buy
  • IBRX Strong Buy
  • Analyst Count
  • ALG 3
  • IBRX 5
  • Target Price
  • ALG $214.00
  • IBRX $11.40
  • AVG Volume (30 Days)
  • ALG 88.9K
  • IBRX 11.3M
  • Earning Date
  • ALG 05-08-2025
  • IBRX 05-12-2025
  • Dividend Yield
  • ALG 0.61%
  • IBRX N/A
  • EPS Growth
  • ALG N/A
  • IBRX N/A
  • EPS
  • ALG 9.60
  • IBRX N/A
  • Revenue
  • ALG $1,593,877,000.00
  • IBRX $31,222,000.00
  • Revenue This Year
  • ALG $0.52
  • IBRX $579.01
  • Revenue Next Year
  • ALG $5.01
  • IBRX $173.61
  • P/E Ratio
  • ALG $20.63
  • IBRX N/A
  • Revenue Growth
  • ALG N/A
  • IBRX 10238.41
  • 52 Week Low
  • ALG $157.07
  • IBRX $1.83
  • 52 Week High
  • ALG $205.62
  • IBRX $7.63
  • Technical
  • Relative Strength Index (RSI)
  • ALG 59.71
  • IBRX 53.05
  • Support Level
  • ALG $195.38
  • IBRX $2.43
  • Resistance Level
  • ALG $203.68
  • IBRX $2.79
  • Average True Range (ATR)
  • ALG 3.33
  • IBRX 0.23
  • MACD
  • ALG -0.28
  • IBRX 0.02
  • Stochastic Oscillator
  • ALG 28.42
  • IBRX 53.80

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: